Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA

• Published in: Journal of general internal medicine : JGIM Vol. 38; no. 16; pp. 3499 - 3508
• Main Authors: Xu, Kevin Y., Schiff, Davida M., Jones, Hendrée E., Martin, Caitlin E., Kelly, Jeannie C., Bierut, Laura J., Carter, Ebony B., Grucza, Richard A.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.12.2023; Springer Nature B.V
• Subjects: Adolescent; Adult; Age; Analgesics, Opioid - therapeutic use; Buprenorphine; Buprenorphine - therapeutic use; Drug abuse; Drug addiction; Ethnicity; Female; Government programs; Hispanic people; Humans; Internal Medicine; Medicaid; Medicine; Medicine & Public Health; Methadone; Methadone - therapeutic use; Middle Aged; Minority & ethnic groups; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders - drug therapy; Opioids; Original Research; Race; Retention; Retrospective Studies; Substance use disorder; United States - epidemiology; Young Adult; United States; United States > US; racial disparities; opioid use disorder; addiction medicine; buprenorphine; methadone; pregnancy

Background Associations between race/ethnicity and medications to treat OUD (MOUD), buprenorphine and methadone, in reproductive-age women have not been thoroughly studied in multi-state samples. Objective To evaluate racial/ethnic variation in buprenorphine and methadone receipt and retention in a...